US pharma major Eli Lilly announced on Friday that Maura Dickler, a prestigious breast cancer researcher, will join Lilly Oncology as vice president of late phase development on May 7, 2018. 10 March 2018
UK biopharma Amryt Pharma has announced another distribution deal for Lojuxta (lomitapide) – this time covering Lebanon, Jordan and Syria. 6 March 2018
Jamie Macdonald is to take over as chief executive of one of the world’s leading contract research organizations after the retirement of the company’s current boss. 6 March 2018
Dermatology specialist Medimetriks Pharmaceuticals has announced that it has divested exclusive US rights for Xepi (ozenoxacin cream), 1% to Cutanea Life Sciences for up to $30 million, with $29 million to be paid in 2018, plus the assumption of $5 million in liabilities related to Xepi. 6 March 2018
Vanda Pharmaceuticals says that Hetlioz (tasimelteon), a circadian regulator, demonstrated significant and clinically meaningful benefits in night- and daytime symptoms of jet lag disorder. 5 March 2018
Japanese pharma major Daiichi Sankyo says it will reorganize its US commercial organization as it continues to maximize opportunities for its current portfolio and prepare for its upcoming oncology pipeline. 5 March 2018
Geneva-based Addex Therapeutics has achieved its stated goal of raising 40 million Swiss francs ($42 million) in a book building process launched on 15 February. 5 March 2018
Acacia Pharma announced on Friday that it had priced its initial public offering (IPO) on the Brussels stock exchange, with the aim of raising 40 million euros ($49 million). 2 March 2018
Japan's medicines regulator the Ministry of Health, Labor and Welfare (MHLW) approved 23 new molecular entities (NMEs) as ethical drugs in 2017, reports Pharma Japan. 1 March 2018
US Attorney General Jeff Sessions yesterday announced the creation of a new effort, the Department of Justice Prescription Interdiction & Litigation (PIL) Task Force, to fight the prescription opioid crisis. 28 February 2018
Switzerland’s Helsinn Group has appointed Paul Rittman as chief executive of its US subsidiary Helsinn Therapeutics, replacing William Mann, who steps down on February 28, 2018. 28 February 2018
The Association of the British Pharmaceutical Industry (ABPI) has expressed significant concern that recommendations set out in the consultation on the Cost-effectiveness Methodology for Immunization Programs and Procurement (CEMIPP) would impact negatively on the health of the nation by making it harder for people to access vaccines on the National Health Service (NHS) in the future. 27 February 2018
Sumitomo Dainippon has appointed Hiroshi Nomura, currently executive vice president, as the firm’s new president and chief executive, effective from 1 April 2018. 27 February 2018
Japanese firms Sumitomo Dainippon and JCR Pharmaceuticals have agreed a licensing deal related to JCR's J-Brain Cargo blood-brain barrier (BBB) penetration technology. 27 February 2018
Kolmar Korea is expected to acquire CJ HealthCare, the 10th-largest pharmaceutical company in South Korea, for around 1.3 trillion won ($1.1 billion). 26 February 2018
Japanese conglomerate Fujifilm Corporation is to spend around four billion yen ($40 million) building a new manufacturing facility for its group company, Toyama Chemical. 23 February 2018
The District Court for the District of Columbia has rejected a bid from Amgen to secure a six-month boost to US exclusivity for Sensipar (cinacalcet). 22 February 2018
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Gan & Lee Pharmaceuticals as reported that its three investigational drugs - GZR18, GZR4, and GZR101 - achieved positive results in Phase II diabetes trials. 17 October 2024
A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget, due on October 30. 17 October 2024
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza Vaccine) to include data from a new safety study involving pregnant women. 17 October 2024
Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma giant Novartis for a small molecule anti-tumor asset. 17 October 2024
Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), an innovative siderophore cephalosporin. 17 October 2024
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024